NIH-funded research R21 grant

Investigating how immune cells communicate and secrete proteins

Official title: Nanoplasmonic Spatiotemporal Imaging of Single-Cell Protein Secretion and Intercellular Communication

Funded at New York University · NIH-10935968 · Data updated 2026-11-12

This study is looking at how immune cells communicate by releasing special proteins, and it's using a new imaging technique to see this process in real-time, which could lead to better treatments for infections and other immune-related conditions.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionNew York University
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 30, 2023
Project endAugust 31, 2025
Funding year2024
Award (this year)$196,819
NIH project number5R21GM151528-02
Project IDNIH-10935968 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with immune system disorders or those undergoing treatment for conditions that affect immune cell function.

Less likely to help

Patients with stable, non-immune related conditions may not receive direct benefits from this research.

What this research studies

This research focuses on understanding the behavior of individual immune cells, particularly how they secrete proteins called cytokines that are crucial for cell communication. By developing a novel imaging technique using plasmonic nanoantenna structures, the study aims to capture real-time data on the timing and spatial dynamics of cytokine release. This approach will help researchers gain insights into the interactions between different immune cell types and improve our understanding of immune responses. Patients may benefit from advancements in immunology and infectious disease diagnosis stemming from this work.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic tools and therapies for immune-related diseases.

How similar studies have gone: While the approach is innovative, similar research has shown promise in understanding immune cell interactions, indicating potential for success.

Where this research is happening

  • New York University
    New York, United States
    Active

Researchers

  • Principal investigator: Kurabayashi, Katsuo — New York University
  • Study coordinator: Kurabayashi, Katsuo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.